|
|
 |
|
Viewing report
|
|
|
|
European Markets for Bone Grafts and Bone Cements
Frost & Sullivan, March 2008, Pages: 138
This Frost & Sullivan research service titled European Markets for Bone Grafts and Bone Cements provides an overview of advancements in the grafting technologies and revenues of the current segments along with a complete analysis of key market drivers, restraints, and trends prevailing in the European market. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: machine bone allografts, standard bone allografts, demineralised bone matrix and bone graft substitutes.
Market Overview
Technological Improvements Reinforce the Case for Allografts in the Bone Grafts and Cements Markets
Traditionally, surgeons have preferred autografts to allografts, as the former takes lesser time to heal and rejuvenate. However, this is set to change with the availability of a wide range of technologically superior bone grafts, which provide surgeons with the flexibility to choose suitable grafts for specific needs. Also, these improved allografts can now be pre-shaped prior to the surgery, considerably reducing the surgery time. End users also prefer allografts for their other significant advantages such as lower hospital and procedure costs, higher success rates, reduced morbidity, pain and blood loss and better stability and rehabilitation.
The rise in the number of published clinical studies substantiating the advantages of allografts has also encouraged surgeons to adopt these grafts. They are further impelled by the availability of machined and standard bone grafts, since unlike autografts, they eliminate the need for an additional surgery. 'As manufacturing processes for machined bone become more efficient and are able to extract more value from the same limited supply pool, the number of units sold is expected to increase,' says the analyst of this research. 'New product designs attract more surgeons and thereby, boost revenues.'
Commercial Tissue Companies to Tie up with Non-profit Organisations to Make Organs and Bones Available for Allografts
The bones and organs in allograft surgeries are mainly sourced from donors who pledge their organs. However, with the numbers of donors dwindling or remaining static for almost a decade, there is a crunch in supply of tissues and raw materials for processing. This public reticence to donate organs is due to a variety of reasons such as religious, social and emotional issues as well as inadequate awareness. Moreover, the availability of specific allografts in certain quantities is partly influenced by the number of donations that are processed.
Non-profit organisations have had bigger success than companies in procuring tissues, since relatives feel less queasy about donating a body to a non-profit organisation than selling it to commercial organisations. To counter this situation, commercial companies need to establish agreements with non-profit tissue banks to procure tissue. 'Once they collaborate, they could offer high-quality training and education to tissue recovery teams to ensure the donated tissues are collected and refrigerated in time so that there are fewer possibilities of contamination,' notes the analyst. 'Timely collection of tissues will also improve the testing and screening procedures.'
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
-Machine bone allografts
-Standard bone allografts
-Demineralised bone matrix
-Bone graft substitutes
Customers who bought this item also bought
U.S. Bone Grafts and Bone Graft Substitutes Markets
Strategic Analysis of the European Bone Graft Substitutes Market
European Womens Healthcare Imaging Market
Bone Densitometers - Global Strategic Business Report
Bisphosphonates and Other Bone-Targeting Compounds in the Treatment of Cancer
Asia Pacific Markets for Dental Bone Graft Substitutes
U.S. and Asia Markets for Bone Morphogenic Proteins in Spine Fusion
U.S. Bone Growth & Spinal Fusion Stimulators Markets
|
|
|
|
